Timber Pharmaceuticals Inc (NYSE American:TMBR)
| 2.99 Delayed Data As of Sep 29 |  -0.04 / -1.32%Today’s Change | 1.20 Today|||52-Week Range 6.00 | +70.86% Year-to-Date |
Latest TMBR News | Press Releases
No recent news for Timber Pharmaceuticals Inc.
Today’s Trading
| Previous close | 3.03 |
| Today’s open | 2.98 |
| Day’s range | 2.98 - 2.99 |
| Volume | 44,198 |
| Average volume (3 months) | 573,594 |
| Market cap | $10.5M |
Data as of 3:59pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +66.43% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IMNNImunon Inc | +0.02 | +2.46% |
| BCDABioCardia Inc | -0.00 | -1.05% |
| ---- | ||
| CMMBChemomab Therapeutic... | 0.00 | 0.00% |
Data as of 3:45pm ET, 09/29/2023
Financials
| Next reporting date | November 13, 2023 |
| EPS forecast (this quarter) | -$0.61 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$9.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Warren, New Jersey |
Forecasts
